companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

PHARMACIE ASSOCIEE AU GROUPE

GRANDE-RIVIERE-Canada

Company Name:
Corporate Name:
PHARMACIE ASSOCIEE AU GROUPE
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 185 Rue LA Grande-Allee O,GRANDE-RIVIERE,QC,Canada 
ZIP Code:
Postal Code:
G0C1V0 
Telephone Number: 4183852121 
Fax Number: 4183854543 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
591205 
USA SIC Description:
Pharmacies 
Number of Employees:
20 to 49 
Sales Amount:
$2.5 to 5 million 
Credit History:
Credit Report:
Excellent 
Contact Person:
Michel Whittom 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
PIECES DAUTOS JLR ENR
PHUC, NGUYEN DDS
PHARMACIE ASSOCIEE AU GROUPE JEAN COU
Next company profile:
PETRO-CANADA
PEINTURE P NICOLAS
PEINTURE P NICOLAS










Company News:
  • Study Data Standards Resources | FDA
    Study Data Standards ResourcesThis page provides quick links to key guidances to support the submission of study data to FDA’s Center for Biologics Evaluation and Research (CBER), Center for
  • Data Standards for Drug and Biological Product Submissions Containing . . .
    9 For additional information on how FDA interprets and intends to implement the electronic submission requirements of section 745A(a) of the FD C Act, see the guidance for industry Providing Regulatory Submissions in Electronic Format–Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act (December 2014)
  • Understanding the Database Lock Process in Clinical Trials
    Conclusion The database lock is a vital step in clinical trials, ensuring data accuracy, integrity, and readiness for analysis and regulatory submission By defining and establishing clear lock criteria early, managing data effectively, and fostering collaboration across all teams, you can significantly reduce the risk of delays or errors
  • Data Lock | Penn Medicine Clinical Research | Perelman School of . . .
    Database lock is a significant milestone in the life cycle of a clinical trial and one of the final steps taken before submitting the information to the FDA It should be done after a final quality check and data validation via the monitor and sponsor team but before data is extracted from the electronic data management group and formatted for
  • Database Lock in Clinical Trials: Ensuring Data Integrity for . . .
    By following these best practices, clinical trials can achieve a successful database lock, ensuring that the data is ready for rigorous analysis and subsequent regulatory submission This process is vital for the credibility of the trial results and the approval of new treatments
  • Database Lock Procedures in Clinical Data Management: A Complete Guide
    Properly executed database lock procedures ensure the integrity, traceability, and regulatory compliance of clinical trial datasets This guide provides an in-depth exploration of database lock steps, best practices, and challenges in clinical research
  • Data Standards for Drug and Biological Product Submissions Containing
    Pursuant to this action, calling for FDA to issue guidance on the use of real-world evidence (RWE) in regulatory decision-making, FDA has created a framework for a program to evaluate the
  • Database Lock in Clinical Trials: Achieving Success
    What is the Main Purpose of Database Lock? The primary purpose of a DBL is to preserve data integrity By ensuring the dataset is complete, accurate, and unaltered after locking, the results of the study remain reliable and consistent What Happens After Database Lock in Clinical Trials? After database lock, the data is sent to the biostatistician for analysis Then, the data goes to the
  • Study Data Standards Update for CBER: Your Guide To A Successful Submission
    FDA Technical Rejection Criteria For Study Data Trial Summary dataset (ts xpt) 1734 must be present for each study in eCTD DM dataset and define xml must 1736 be submitted in module 4
  • Database Lock in Clinical Trials: Process Best Practices
    Learn about the database lock process in clinical trials This guide covers its importance for data integrity, the steps involved, and key team responsibilities




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer